We cover
ASCO GU | Genitourinary Cancers Symposium
ASCO GU 2025
ASCO GI 2025
We met leading experts
Get their insight into current studies and new knowledge in oncology
ASCO GU 2025
Real-World Treatment Patterns of Nivolumab + Cabozantinib Compared with Other 1L IO Combinations in mRCC
/ Cherrishe Brown-Bickerstaff / Jan Andreasen
Bone Pain as a Key Prognostic Indicator in Castration-Sensitive Prostate Cancer
/ Deniz Tural / Jan Andreasen
Real-Life Data Confirms Avelumab Maintenance Benefits in Metastatic Urothelial Carcinoma
/ Deniz Tural / Jan Andreasen
Cabozantinib Real-World Effectiveness in the Second-Line Setting of Metastatic Renal Cell Carcinoma
/ Martin Zarba / Jan Andreasen
Danish Study Reveals Doubling of Kidney Cancer Cases and a Growing Gender Gap
/ Johanne Ahrenfeldt / Jan Andreasen